Search PubMed⌕ Search

PubMed · 6096638

An improved method for preparing DNA from human brain.

Abstract

The preparation of DNA from human brain by conventional protease and RNAase digestion, phenol-chloroform extraction and ethanol precipitation results in very low yields. This is probably due to interference by lipid present at very high levels in this tissue. We have overcome this by solubilizing the initial tissue homogenate by heating at 60 degrees C for 30 min in sodium dodecyl sulphate. This results in a threefold increase in yield and a considerable reduction in preparation time. The molecular weight of the DNA is greater than 20 X 10(6) milion.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Saldanha, A Gannicliffe, R F Itzhaki. 1984. An improved method for preparing DNA from human brain.. https://doi.org/10.1016/0165-0270(84)90089-x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A subgroup of spinocerebellar ataxias defective in DNA damage responses.

A subgroup of human autosomal recessive ataxias is also characterized by disturbances of eye movement or oculomotor apraxia. These include ataxia telangiectasia (A-T); ataxia telangiectasia like disorder (ATLD); ataxia oculomotor apraxia type 1 (AOA1) and ataxia oculomotor apraxia type 2 (AOA2). What appears to be emerging is that all of these have in common some form of defect in DNA damage response which could account for the neurodegenerative changes seen in these disorders. We describe here sensitivity to DNA damaging agents in AOA1 and evidence that these cells have a defect in single strand break repair. Comparison is made with what appears to be a novel form of AOA (AOA3) which also shows sensitivity to agents that lead to single strand breaks in DNA as well as a reduced capacity to repair these breaks. AOA3 cells are defective in the DNA damage-induced p53 response. This defect can be overcome by incubation with the mdm2 antagonists, nutlins, but combined treatment with nutlins and DNA damage does not enhance the response. We also show that AOA3 cells are deficient in p73 activation after DNA damage. These data provide further evidence that different forms of AOA have in common a reduced capacity to cope with damage to DNA, which may account for the neurodegeneration observed in these syndromes.

Brain Chemistry↗